Tag: Eye Drops
FDA: Do Not Use Dr. Berne’s and LightEyez Eye Drops Due to Bacteria, Fungus
No adverse events from using the drops have been reported so far, but the FDA warns the products should be thrown out because using them could lead to vision-threatening infections
FDA Approves Xdemvy for Demodex Blepharitis
Significant improvements seen in reduction of collarettes in as early as two weeks
Atropine 0.01 Percent Eye Drops Do Not Slow Myopia Progression
Findings seen in children aged 5 to 12 years with low-to-moderate bilateral myopia
Low-Dose Atropine Treatment Slows Pediatric Myopia Progression
Greater benefits seen with 0.01 percent dose over three years versus 0.02 percent dose
Another Death, More Cases of Vision Loss Linked to Tainted Eye Drops
In all, four people have died, with one new death now being reported by the CDC
Water-Free Cyclosporine Eye Drop, 0.1 Percent, Effective for Dry Eye
Improvements seen for corneal epithelial damage, dryness symptoms
FDA Finds Contamination Issues at Eye Drops Plant
U.S. regulators discovered long list of sanitation problems at factory in India that made eye drops linked to outbreak of serious eye infections
Two More Brands of Eye Drops Recalled Over Infection Risks
Pharmedica and Apotex voluntarily recalling products due to issues with sterility
FDA Widens Warning for Contaminated Eye Products
At least 16 patients had been hospitalized earlier for an outbreak of the 'rare, extensively drug-resistant' Pseudomonas aeruginosa bacteria
0.05 Percent Atropine Eye Drops Result in Lower Incidence of Myopia
Incidence of myopia and percentage of patients with fast myopic shift lower with 0.05 percent atropine versus placebo among children aged 4 to 9 years without myopia at baseline
